Etomidate Injection, Solution
Product Images NDC 65219-447

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Etomidate (NDC 65219-447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Eto04 0000 01)

FDA Label Image

Fresenius Kabi Logo (Eto04 0000 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Vial Label)

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Vial Label)
Etomidate Injection is a sterile, nonpyrogenic solution for intravenous use only that comes in a 10 mL single-dose vial. Each mL of the injection contains 2 mg of Etomidate USP, 35% v/v of propylene glycol USP, and water for injection USP q.s. It is usually used as directed by a physician, and any unused portion should be discarded. The drug should be stored at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. The package insert contains information on the usual dosage. No other information is available.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Carton)

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Carton)
This appears to be a product label for Etomidate Injection. It includes information on the dimensions of the product, the dosage instructions, and details for batch overprinting. It also includes storage instructions and information on the manufacturer. This product is for intravenous use only and is dispensed in single-dose vials.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Vial Label)

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Vial Label)
This is a description of a medication called Etomidate, which is available only by prescription. Each mL contains 2mg of Etomidate along with propylene glycol and water for injection. It is usually administered through injection and the unused portion should be discarded. This medication is sterile and nonpyrogenic and should be stored at room temperature. The package insert should be consulted for the recommended dosage. The medication is packaged in a 20 mL single-dose vial. The text also contains a code for identification purposes.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Carton)

Package Label (PRINCIPAL DISPLAY –Etomidate Injection, USP Single-Dose Carton)
This is a description of a pharmaceutical product, specifically a solution of Etomidate Injection, USP. The product comes in 10 x 20mL single-dose vials, for intravenous use only, and is intended to be used in accordance with the package insert. The solution consists of 40mg/20mL (2mg/mL) of Etomidate, as well as propylene glycol USP and water for injection USP. The recommended storage temperature is 20-25°C (68°-77°F). The label includes the batch number, expiration date, and other details that will be printed online during packing. The brand name is not included in the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.